Clinical Trial Update: Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers [Phase 2]

View source ↗

Summary

Completed Phase 2 study evaluating the pharmacokinetics and safety of A006 in healthy volunteers, sponsored by Amphastar Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• A006

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED